TY - JOUR
T1 - Integrin α2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-α-driven colon cancer cells
AU - Sawhney, Rajinder S.
AU - Sharma, Bhavya
AU - Humphrey, Lisa E.
AU - Brattain, Michael G.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2003/5/30
Y1 - 2003/5/30
N2 - Recently, we have shown that autocrine transforming growth factor-α (TGF-α) controls the expression of integrin α2, cell adhesion to collagen IV and motility in highly progressed HCT116 colon cancer cells (Sawhney, R. S., Zhou, G-H. K., Humphrey, L. E., Ghosh, P., Kreisberg, J. I., and Brattain, M. G. (2002) J. Biol. Chem. 277, 75-86). We now report that expression of basal integrin α2 and its biological effects are controlled by constitutive activation of the extracellular signal-regulated/mitogen-activated protein kinase (ERK/MAPK) pathway. Treatment of cells with selective mitogena-ctivated protein kinase kinase (MEK) inhibitors PD098059 and U0126 showed that integrin α2 expression, cell adhesion, and activation of ERK are inhibited in a parallel concentration-dependent fashion. Moreover, autocrine TGF-α-mediated epidermal growth factor receptor activation was shown to control the constitutive activation of the ERK/MAPK pathway, since neutralizing antibody to the epidermal growth factor receptor was able to block basal ERK activity. TGF-α antisense-transfected cells also showed attenuated activation of ERK. Using a real time electric cell impedance sensing technique, it was shown that ERK-dependent integrin α2-mediated cell micromotion signaling is controlled by autocrine TGF-α. Thus, this study implicates ERK/MAPK signaling activated by endogenous TGF-α as one of the mechanistic features controlling metastatic spread.
AB - Recently, we have shown that autocrine transforming growth factor-α (TGF-α) controls the expression of integrin α2, cell adhesion to collagen IV and motility in highly progressed HCT116 colon cancer cells (Sawhney, R. S., Zhou, G-H. K., Humphrey, L. E., Ghosh, P., Kreisberg, J. I., and Brattain, M. G. (2002) J. Biol. Chem. 277, 75-86). We now report that expression of basal integrin α2 and its biological effects are controlled by constitutive activation of the extracellular signal-regulated/mitogen-activated protein kinase (ERK/MAPK) pathway. Treatment of cells with selective mitogena-ctivated protein kinase kinase (MEK) inhibitors PD098059 and U0126 showed that integrin α2 expression, cell adhesion, and activation of ERK are inhibited in a parallel concentration-dependent fashion. Moreover, autocrine TGF-α-mediated epidermal growth factor receptor activation was shown to control the constitutive activation of the ERK/MAPK pathway, since neutralizing antibody to the epidermal growth factor receptor was able to block basal ERK activity. TGF-α antisense-transfected cells also showed attenuated activation of ERK. Using a real time electric cell impedance sensing technique, it was shown that ERK-dependent integrin α2-mediated cell micromotion signaling is controlled by autocrine TGF-α. Thus, this study implicates ERK/MAPK signaling activated by endogenous TGF-α as one of the mechanistic features controlling metastatic spread.
UR - http://www.scopus.com/inward/record.url?scp=0038165438&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038165438&partnerID=8YFLogxK
U2 - 10.1074/jbc.M213162200
DO - 10.1074/jbc.M213162200
M3 - Article
C2 - 12657625
AN - SCOPUS:0038165438
VL - 278
SP - 19861
EP - 19869
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
SN - 0021-9258
IS - 22
ER -